Key Metrics
CiteScore 

7.8
Impact Factor 

< 5
Scite Index 

0.84 5-Year SI

SJR 

Q2Hematology

SNIP 

1.44
Recommended pre-submission checks
Powered by 

Topics Covered on Transplantation and Cellular Therapy
Transplantation and Cellular Therapy Journal Specifications
Indexed in the following public directories
Web of Science
Scopus
SJR
| Overview | |
| Publisher | ELSEVIER SCIENCE INC |
| Frequency | Monthly |
| General Details |
View less
Planning to publish in Transplantation and Cellular Therapy ?
Upload your Manuscript to get
- Degree of match
- Common matching concepts
- Additional journal recommendations

Recently Published Papers in Transplantation and Cellular Therapy
Cytomegalovirus Interstitial Pneumonia: A Plague of Marrow Transplant That the Field Solved.
- 1 Jul 2026
- Transplantation and cellular therapy
Rectal Colonization with Multidrug-Resistant Organisms and Subsequent Bloodstream Infections in Hematological Patients Undergoing Cellular Therapies.
- 1 Jul 2026
- Transplantation and cellular therapy
Do We Sin When Treating Patients with Higher-Risk Myelodysplastic Syndromes?
- 1 Jul 2026
- Transplantation and cellular therapy
Adverse Social Determinants Independently Predict Outcomes After Allogeneic HSCT.
- 1 Jul 2026
- Transplantation and cellular therapy
Simplification of Hematopoietic Stem Cell Transplantation and Continued FACT Accreditation: Strategies for Low- and Middle-Income Countries.
- 1 Jul 2026
- Transplantation and cellular therapy
The Last Mile in CAR-T Cell Therapy.
- 1 Jul 2026
- Transplantation and cellular therapy
Cytomegalovirus Interstitial Pneumonia: A Plague of Marrow Transplant That the Field Solved.
- 1 Jul 2026
- Transplantation and cellular therapy
Rectal Colonization with Multidrug-Resistant Organisms and Subsequent Bloodstream Infections in Hematological Patients Undergoing Cellular Therapies.
- 1 Jul 2026
- Transplantation and cellular therapy
Do We Sin When Treating Patients with Higher-Risk Myelodysplastic Syndromes?
- 1 Jul 2026
- Transplantation and cellular therapy
Adverse Social Determinants Independently Predict Outcomes After Allogeneic HSCT.
- 1 Jul 2026
- Transplantation and cellular therapy
Simplification of Hematopoietic Stem Cell Transplantation and Continued FACT Accreditation: Strategies for Low- and Middle-Income Countries.
- 1 Jul 2026
- Transplantation and cellular therapy
The Last Mile in CAR-T Cell Therapy.
- 1 Jul 2026
- Transplantation and cellular therapy